Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
Opinion Statement: The therapeutic landscape of gastroenteropancreatic-neuroendocrine tumors (GEP-NETs) has evolved significantly in recent years. Current and emerging treatment options include somatostatin analogs, radiolabeled somatostatin analogs, the mTOR inhibitor everolimus, and the tyrosine k...
| Published in: | Current Treatment Options in Oncology Vol. 18; no. 3; pp. 1 - 15 |
|---|---|
| Main Authors: | , |
| Format: | research Journal Article |
| Published: |
Springer Nature
Mar2017
|
| Online Access: | View this record in EBSCOhost |